Cargando…
Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: A case-control study
INTRODUCTION: Secondary hyperparathyroidism (SHPT) is an insidious disease that develops early in the course of chronic kidney disease (CKD) and increases in severity as the glomerular filtration rate deteriorates. Recent studies have identified fibroblast growth factor-23 (FGF23) as a new protein w...
Autores principales: | Sliem, Hamdy, Tawfik, Gamal, Moustafa, Fadia, Zaki, Heba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124995/ https://www.ncbi.nlm.nih.gov/pubmed/21731867 http://dx.doi.org/10.4103/2230-8210.81939 |
Ejemplares similares
-
Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end-stage renal disease: A case control study
por: Sliem, Hamdy, et al.
Publicado: (2011) -
Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease
por: Konstantinidis, Ioannis, et al.
Publicado: (2013) -
Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
por: Chertok Shacham, Elena, et al.
Publicado: (2023) -
Pattern of systemic lupus erythematosus in Egyptian patients: the impact of disease activity on the quality of life
por: Hamdy, Sliem, et al.
Publicado: (2010) -
Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)